Objective To examine mortality rates in the largest systemic lupus erythematosus (SLE) cohort
ever assembled. Methods Our sample was a multisite international SLE cohort (23 centers…

Objective There is increasing evidence in support of an association between systemic lupus
erythematosus (SLE) and malignancy, but in earlier studies the association could not be …

To determine the safety and efficacy of viscosupplementation with hylan GF 20, a cross-linked
hyaluronan preparation, used either alone or in combination with continuous non-…

Objective. The Canadian Rheumatology Association (CRA) has developed recommendations
for the pharmacological management of rheumatoid arthritis (RA) with traditional and …

OBJECTIVE: To update estimates of cancer risk in SLE relative to the general population.
METHODS: A multisite international SLE cohort was linked with regional tumor registries. …

Objective: To examine if, in systemic lupus erythaematosus (SLE), exposure to immunosuppressive
therapy (cyclophosphamide, azathioprine, methotrexate) increases cancer risk. …

Objective Several advanced therapies have been licensed across the related conditions of
psoriatic arthritis (PsA), Crohn disease (CD), ulcerative colitis (UC), and noninfectious uveitis. …

Objective. The Canadian Rheumatology Association (CRA) has developed recommendations
for the pharmacological management of rheumatoid arthritis (RA) with traditional and …

OBJECTIVES: The (ever) prevalence of neuropsychiatric systemic lupus erythematosus (NPSLE)
can vary widely depending on the definition used. We determined the prevalence of …

Objective To assess the potential benefits of methotrexate in patients with systemic lupus
erythematosus (SLE). Methods A 12‐month, double‐blind, placebo‐controlled trial of …